SciELO - Scientific Electronic Library Online

 
vol.78 número5Etiología del síndrome febril prolongado en niñosActividad física y obesidad en niños con asma índice de autoresíndice de materiabúsqueda de artículos
Home Pagelista alfabética de revistas  

Servicios Personalizados

Revista

Articulo

Indicadores

Links relacionados

Compartir


Revista chilena de pediatría

versión impresa ISSN 0370-4106

Resumen

RAIMANN T, XIMENA et al. Ketogenic Diet in Refractory Epilepsy: efficacy, evolution and long-term complications. Rev. chil. pediatr. [online]. 2007, vol.78, n.5, pp.477-481. ISSN 0370-4106.  http://dx.doi.org/10.4067/S0370-41062007000500004.

Background: Ketogenic diet (KD) represents an alternative in treatment of refractory epilepsy (RE). Objective: To evaluate the efficacy of the diet and the frequency of complications in patients belonging to the KD Program from Luis Calvo Mackenna Children's Hospital (HLCM). Methods: Evaluation of all children enrolled in the program between 1999 and 2004, with analysis every 6 months of the diet efficacy, digestive tolerance, nutritional status, cholesterol levels and nephrolithiasis. Results: 21 children were admitted, 14 boys, age between 6 months - 17 years-old. 76%, 71% and 67% of patients followed KD at 6, 12 and 18 months, respectively, with KD efficacy of 67%. At 12 months, 24% of patients did not present seizures. At 18 months, 85% remained close to ideal body weight (15% obesity) and height/age Z score decreased (-0,7 ± 0,4; p < 0,05). Total cholesterol significantly increased at 6 months (64% hypercholesterolemia; decreased to 15% at 18 months). 2 patients developed nephrolithiasis. Conclusions: The study shows high efficacy of the KD for treatment of refractory epilepsy, with low rate of complications. It should be considered as a therapeutic alternative for these patients

Palabras clave : ketogenic diet; refractory epilepsy; seizures; children.

        · resumen en Español     · texto en Español     · Español ( pdf )

 

Creative Commons License Todo el contenido de esta revista, excepto dónde está identificado, está bajo una Licencia Creative Commons